MedTrace Logo

SHMT1 Polymorphism in Parkinson's Disease,

NCT04706065 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-06-02

No results posted yet for this study

Summary

Parkinson Disease (PD) is the most common movement disorder and represents the second most common degenerative disease of the central nervous system . SHMT has been shown to be associated with various diseases.

Conditions

  • Study the Role of SHMT1 Polymorphism in Parkinson Disease

Interventions

GENETIC

SHMT1 polymorphism

It is to identify the role of SHMT1polymorphism in PD and examine the relationship between it and Severity of PD.

Sponsors & Collaborators

  • Aswan University Hospital

    collaborator OTHER

  • Assiut University

    lead OTHER

Principal Investigators

  • Abeer a tony, MD · Assistant professor

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-07-31
Completion
2022-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04706065 on ClinicalTrials.gov